By 2028, Global Demand for Gene Synthesis Market Will Surpass $6.58 Billion at 17.9% CAGR Growth: Vantage Market

WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) — Vantage Market Research’s recent analysis of the Global Gene Synthesis Market finds that rising prevalence of infectious diseases as well as chronic diseases is expediting market growth. Primarily driven by high efficiency, the total Global Gene Synthesis Market is estimated to reach USD 6.58 Billion by 2028, up from USD 2.16 Billion in 2021, at a compound annual growth rate (CAGR) of 17.9%.

Furthermore, supportive government policies associated with synthetic biology and surging investments from government as well as major players to augment the growth of the Global Gene Synthesis Market, states Vantage Market Research, in a report, titled “Gene Synthesis Market by End User (Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations), by Method (Oligonucleotide Synthesis, Gene Assembly), by Region (North America, Europe, Asia Pacific, Latin America) – Global Industry Assessment (2016 – 2021) & Forecast (2022 – 2028)”.

Please Check Out Our Free Sample Reports and Make a More Informed Decision:

Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/gene-synthesis-market-1259/request-sample

(Sample reports are a great way to test our in-depth reports or study before you make a purchase)

• The newly updated, 170+ page reports provide an in-depth analysis of the COVID-19 virus and pandemic.

• Using industry data and interview with experts, you can learn about topics such as regional impact analysis, global forecast, competitive landscape analysis, size & share of regional markets.

• We offer these reports in PDF format so you can read them on your computer and print them out

• Free sample includes, Industry Operating Conditions, Industry Market Size, Profitability Analysis, SWOT Analysis, Industry Major Players, Historical and Forecast, Growth Porter’s 5 Forces Analysis, Revenue Forecasts, Industry Trends, Industry Financial Ratios.

• The report also presents the country-wise and region-wise analysis of the Vantage Market Research and includes a detailed analysis of the key factors affecting the growth of the market.

• Sample Report further sheds light on the Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis, to offer the readers an advantage over others.

Story continues

List of Prominent Players in the Gene Synthesis Market:

• Merck KGaA

• Genewiz Inc.

• Eurofins Genomics

• Thermo Fisher Scientific

• Gen Script

Market Dynamics:

Driver:

Escalated Adoption of Gene Therapy Technique in Molecular Biology

The significant development in gene therapy and molecular biology is development and use of various state of the art gene editing techniques for editing purposes. Therefore, there has been a remarkable progress in developing gene therapy for its adoption in molecular biology. Availability of user-friendly gene therapy system, development of genome engineering, and ability of gene therapy for enabling rapid genome-wide interrogation of gene function are projected to accelerate the adoption of Gene therapy gene editing technologies in molecular biology. Consequently, driving the gene synthesis market growth over the forecast period.

Purchase This Premium Report Now @ https://www.vantagemarketresearch.com/buy-now/gene-synthesis-market-1259/1

Benefits of Purchasing Gene Synthesis Market Reports:

• Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.

• Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.

• Assured Quality: Focuses on accuracy and quality of reports.

• Incomparable Skills: Analysts provide in-depth insights into reports.

Increasing Chronic as well as infectious disease prevalence across the globe

The escalating prevalence of infectious diseases has led to advancements in Research and development (R&D) through gene therapy, which is expected to boost the overall global gene therapy demand. Precise, early, and quick treatment through genomic, transcriptome or other multi-omics of cells causing chronic and infectious diseases is resulting in surge in demand for of gene therapy. As a result, driving the gene synthesis market growth over the forecast period.

COVID-19 Impact Analysis:

The COVID-19 outbreak has affected various industries worldwide. Governments across the world implemented strict lockdown measures and social distancing norms in order to restrict the swift spread of the pandemic. Manufacturing facilities around the world were shut down during the initial stages of the pandemic. Moreover, the economic crisis after the pandemic might lead to a significant delay in the commercial roll-out of the industry. Small and medium-scale companies are the backbone of technology providers and are witnessing a steep drop in revenue since the emergence of the pandemic in 2020. Hence, market players faced numerous challenges as disruptions in the supply chain were observed. However, things will improve in the second half of 2022 as more supplies will come online. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data points:

1. Impact Assessment of COVID-19 Pandemic

   1. North America

   2. Europe

   3. Asia Pacific

   4. Latin America

   5. Middle East & Africa

2. Quarterly Market Revenue Forecast by Asia Pacific 2020 & 2021

3. Key Strategies Undertaken by Companies to Tackle COVID-19

4. Long Term Dynamics

5. Short Term Dynamics

Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/gene-synthesis-market-1259

The report on Gene Synthesis Market highlights:

• Assessment of the market

• Premium Insights

• Competitive Landscape

• COVID Impact Analysis

• Historic Data, Estimates and Forecast

• Company Profiles

• Global and Regional Dynamics

Regional Analysis:

North America Dominates the Global Gene Synthesis Market

North America has dominated the Global Gene Synthesis Market in 2021 and is likely to continue the same trend during the forecast period. This is attributable to the developed healthcare infrastructure and well-established laboratory facilities. Moreover, presence of major players and increasing government initiatives concerning to training and implementation of synthetic biology programs is further propelling the market growth in the region.

Asia Pacific is likely to witness fastest growth in the Gene Synthesis Market during the forecast period. This is attributable to rising investments by global companies. Also, presence of emerging nations, such as China and India along with some key companies in region is further fuelling the market growth.

Browse market data Tables and Figures spread through 179 Pages and in-depth TOC on “Gene Synthesis Market by End User (Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations), by Method (Oligonucleotide Synthesis, Gene Assembly), by Region (North America, Europe, Asia Pacific, Latin America) – Global Industry Assessment (2016 – 2021) & Forecast (2022 – 2028)” View detailed Research Report here – https://www.vantagemarketresearch.com/press-release/gene-synthesis-market-436943

Key questions answered in the report:

• Which regional market will show the highest and rapid growth?

• Which are the top five players of the Gene Synthesis Market?

• How will the Gene Synthesis Market change in the upcoming six years?

• Which application and product will take a lion’s share of the Gene Synthesis Market?

• What is the Gene Synthesis market drivers and restrictions?

• What will be the CAGR and size of the Gene Synthesis Market throughout the forecast period?

Recent Developments:

August, 2019: Eurofins Genomics LLC (U.S.) announced the acquisition of Blue Heron Biotech, a company specializing in advanced gene synthesis. The acquisition provides valuable synergies for both companies due to the inherent connection between their main product segments—oligonucleotides, sequencing and synthetic genes, and strengthens Eurofins Genomics offer in the synthetic biology market.

January 2022: Codex DNA Signs Early Access Collaboration and Licensing Agreement with Pfizer to Further Develop Codex DNA’s Novel Enzymatic DNA Synthesis Technology for Pfizer’s use in its Research and Development of mRNA-based Vaccines and Biotherapies.

This market titled “Gene Synthesis Market” will cover exclusive information in terms of Regional Analysis, Forecast, and Quantitative Data – Units, Key Market Trends, and various others as mentioned below:

Customization of the Report:

The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

Download Free Sample Report Now @